sorbitol (Ora-Sweet SF, PCCA Sweet-SF, PCCA Syrup Vehicle, PCCA-Plus, Numoisyn)
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
GENERIC NAME: sorbitol
BRAND NAMES: Ora-Sweet SF, PCCA Sweet-SF, PCCA Syrup Vehicle, PCCA-Plus, Numoisyn
DRUG CLASS AND MECHANISM: Sorbitol is a sugar alcohol naturally found in fruits. Its chemical properties allow it to have multiple actions within the body. Its sweetening properties allow it to be used as a low-calorie sweetener in medicinal solutions. Its hyperosmotic properties allow it to work as a laxative, drawing water into the colon from surrounding body tissues to allow softening of stool and relieve constipation. This ability to draw in water also allows it to be used in saliva substitutes to relieve dry mouth and during transurethral prostatectomy as a urinary bladder wash. The FDA approved sorbitol in February 1978.
GENERIC AVAILABLE: Yes
PREPARATIONS: Irrigation Solution 3%, 3.3%; Oral Solution 70%, Oral Suspension, Oral Syrup, Lozenge
STORAGE: Sorbitol should be stored at room temperature, 25 C (77 F). Heating above 66 C (150 F) or freezing should be avoided.
PRESCRIBED FOR: Sorbitol is used as a sweetening agent in medicinal syrups and suspensions, as a laxative to relieve constipation, as a saliva substitute, for bladder irrigation (wash) in transurethral prostatic resection or other transurethral surgical procedures, and as a diuretic to induce urination.
DOSING: The initial dose for use as a laxative in adults is 30-150 mL of an oral 70% solution, or 120 mL of a 25% to 30% rectal enema solution. For transurethral surgical procedures, a continuous wash of 3% to 3.3% solution is used.
DRUG INTERACTIONS: Combining sorbitol with calcium/sodium polystyrene sulfonate should be avoided due to the significant risk of causing death of gut tissue (intestinal necrosis).
PREGNANCY: There are no adequate studies of sorbitol in pregnant women.
NURSING MOTHERS: Sorbitol should be used cautiously by nursing mothers.
SIDE EFFECTS: Sorbitol can cause abdominal discomfort, diarrhea, dry mouth, nausea, and vomiting. It may also cause fluid retention in tissues (edema), dehydration, loss of electrolytes, increased blood sugar, and acidification of blood due to lactate production.
REFERENCE: FDA Sorbitol Prescribing Information
Medically Reviewed by a Doctor on 5/15/2014
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index